Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anti-VEGFR3 Monoclonal Antibody IMC-3C5

Known as: Anti-VEGFR3 MoAb IMC-3C5, IMC-3C5 
A fully-human monoclonal antibody directed against human vascular endothelial growth factor receptor 3 (VEGFR-3; Flt-4) with antiangiogenic activity… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
To summarize and clarify the association between vascular endothelial growth factor (VEGF) and vascular endothelial growth factor… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Review
2016
Review
2016
Cancer metastasis which predominantly occurs through blood and lymphatic vessels, is the leading cause of death in cancer… Expand
  • table 1
  • table 2
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND The management of advanced neuroendocrine tumors (NETs) has recently changed. We assessed the activity of pazopanib… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2014
2014
Objectives: (1) Three-dimensionally (3D) visualize the cochlear vessels and blood-labyrinth barrier. (2) Analyze the expression… Expand
  • figure 2
  • figure 1
  • figure 4
  • figure 3
  • figure 6
Is this relevant?
2013
2013
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Recent studies indicate that while chemotherapy can… Expand
Is this relevant?
2011
2011
Here, we show that a novel Rspo1-Wnt-Vegfc-Vegfr3 signaling pathway plays an essential role in developmental angiogenesis. A… Expand
Is this relevant?
2011
2011
TPS150 Background: Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) and its ligands, VEGF-C and VEGF-D, control tumor… Expand
Is this relevant?
2005
2005
Vascular endothelial growth factor receptor 2 (VEGFR2/Flk-1)-positive cells derived from embryonic stem (ES) cells serve as… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?